Dr. Lauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
515 SW Campus Dr
Portland, OR 97239Phone+1 503-494-8093
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Ophthalmology, 1995 - 1999
- University of Oklahoma Health Sciences CenterInternship, Internal Medicine, 1994 - 1995
- University of Oklahoma College of MedicineClass of 1994
- University of RochesterBA, Biology / French, 1984 - 1988
Certifications & Licensure
- WA State Medical License 2005 - 2026
- OR State Medical License 1999 - 2025
- OK State Medical License 1995 - 1996
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- Pilot Study of OCT Versus Fluorescein Angiography in DME Start of enrollment: 2013 Jun 01
- OCT in Retinal Vein Occlusions Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results.Paul Yang, David Birch, Andreas Lauer, Robert Sisk, Rajiv Anand
American Journal of Ophthalmology. 2025-03-01 - 7 citationsSafety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral d...Paul Yang, Laura P Pardon, Allen C Ho, Andreas K Lauer, Dan Yoon
Lancet. 2024-09-07 - 1 citationsPreformed Vesicle Approach to LNP Manufacturing Enhances Retinal mRNA Delivery.Yulia Eygeris, Michael I Henderson, Allison G Curtis, Antony Jozić, Jonathan Stoddard
Small. 2024-09-01
Journal Articles
- Classification of Choroidal Neovascularization Using Projection-Resolved Optical Coherence Tomographic AngiographyJ Peter Campbell, Thomas Hwang, Steven T Bailey, Christina Flaxel, Brandon Lujan, David Huang, Andreas Lauer, Lee Kiang, Investigative Ophthalmology and Visual Science
Press Mentions
- OHSU Experts Elected to the National Academy of Medicine, One of the Highest Honors in the Fields of Health, MedicineOctober 21st, 2024
- AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-linked Retinitis Pigmentosa at the 45th Macula Society Annual MeetingJune 6th, 2022
- Let’s Talk About Gene Therapy for Inherited Retinal DiseasesAugust 11th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: